Should ultrathin strut drug eluting stents be considered the new benchmark for novel coronary stents approval? The complex interplay between stent strut thickness, polymeric carriers and antiproliferative drugs.
作者信息
Lupi Alessandro, Schaffer Alon, Bongo Angelo Sante
机构信息
Cardiology Division, Ospedali Riuniti di Domodossola e Verbania, VCO, Omegna, Italy.
2nd Cardiology Division, "Maggiore della Carità" Hospital, Novara, Italy.
出版信息
J Thorac Dis. 2018 Feb;10(2):678-681. doi: 10.21037/jtd.2018.01.108.
Abstract
摘要
相似文献
1
Should ultrathin strut drug eluting stents be considered the new benchmark for novel coronary stents approval? The complex interplay between stent strut thickness, polymeric carriers and antiproliferative drugs.超薄支柱药物洗脱支架应被视为新型冠状动脉支架获批的新基准吗？支架支柱厚度、聚合物载体和抗增殖药物之间的复杂相互作用。
J Thorac Dis. 2018 Feb;10(2):678-681. doi: 10.21037/jtd.2018.01.108.
2
Newer-Generation Ultrathin Strut Drug-Eluting Stents Versus Older Second-Generation Thicker Strut Drug-Eluting Stents for Coronary Artery Disease.新一代超小径药物洗脱支架与上一代较厚支架药物洗脱支架治疗冠状动脉疾病的比较。
Circulation. 2018 Nov 13;138(20):2216-2226. doi: 10.1161/CIRCULATIONAHA.118.034456.
3
Long-Term Effect of Ultrathin-Strut Versus Thin-Strut Drug-Eluting Stents in Patients With Small Vessel Coronary Artery Disease Undergoing Percutaneous Coronary Intervention: A Subgroup Analysis of the BIOSCIENCE Randomized Trial.经皮冠状动脉介入治疗中小血管病变患者应用超薄壁支架与薄壁药物洗脱支架的长期疗效：BIOSCIENCE 随机试验的亚组分析。
Circ Cardiovasc Interv. 2019 Aug;12(8):e008024. doi: 10.1161/CIRCINTERVENTIONS.119.008024. Epub 2019 Aug 6.
4
Outcomes in Patients Treated With Thin-Strut, Very Thin-Strut, or Ultrathin-Strut Drug-Eluting Stents in Small Coronary Vessels: A Prespecified Analysis of the Randomized BIO-RESORT Trial.小血管病变患者中应用薄支架、超薄支架或极薄支架药物洗脱支架的临床结局：随机 BIO-RESORT 试验的预设分析。
JAMA Cardiol. 2019 Jul 1;4(7):659-669. doi: 10.1001/jamacardio.2019.1776.
5
Outcomes of patients treated with ultrathin-strut biodegradable polymer sirolimus-eluting stents versus fluoropolymer-based everolimus-eluting stents: a meta-analysis of randomised trials.采用超薄支架生物可降解聚合物西罗莫司洗脱支架与含氟聚合物依维莫司洗脱支架治疗患者的结局：随机试验的荟萃分析。
EuroIntervention. 2018 Jun 20;14(2):224-231. doi: 10.4244/EIJ-D-18-00024.
6
Ultrathin strut biodegradable polymer sirolimus-eluting stent versus durable polymer everolimus-eluting stent for percutaneous coronary revascularisation (BIOSCIENCE): a randomised, single-blind, non-inferiority trial.超薄支架可生物降解聚合物西罗莫司洗脱支架与耐用聚合物依维莫司洗脱支架经皮冠状动脉血运重建（BIOSCIENCE）：一项随机、单盲、非劣效性试验。
Lancet. 2014 Dec 13;384(9960):2111-22. doi: 10.1016/S0140-6736(14)61038-2. Epub 2014 Sep 1.
7
A randomized optical coherence tomography study of coronary stent strut coverage and luminal protrusion with rapamycin-eluting stents.随机光学相干断层成像研究雷帕霉素洗脱支架的冠状动脉支架梁覆盖和管腔突出。
JACC Cardiovasc Interv. 2009 May;2(5):437-44. doi: 10.1016/j.jcin.2009.01.010.
8
Serial Assessment of Strut Coverage of Biodegradable Polymer Drug-Eluting Stent at 1, 2, and 3 Months After Stent Implantation by Optical Frequency Domain Imaging: The DISCOVERY 1TO3 Study (Evaluation With OFDI of Strut Coverage of Terumo New Drug Eluting Stent With Biodegradable Polymer at 1, 2, and 3 Months).光学相干断层扫描成像在药物洗脱支架置入后 1、2、3 个月时对生物可降解聚合物的支架贴壁情况的连续评估：DISCOVERY 1TO3 研究（应用光学相干断层扫描成像对三个月内新型药物洗脱生物可降解聚合物支架贴壁情况的评估）
Circ Cardiovasc Interv. 2017 Dec;10(12). doi: 10.1161/CIRCINTERVENTIONS.116.004801.
9
Ultrathin-strut, biodegradable-polymer, sirolimus-eluting stents versus thin-strut, durable-polymer, everolimus-eluting stents for percutaneous coronary revascularisation: 5-year outcomes of the BIOSCIENCE randomised trial.超薄支架、可生物降解聚合物、西罗莫司洗脱支架与薄支架、耐用聚合物、依维莫司洗脱支架经皮冠状动脉血运重建：BIOSCIENCE 随机试验 5 年结果。
Lancet. 2018 Sep 1;392(10149):737-746. doi: 10.1016/S0140-6736(18)31715-X. Epub 2018 Aug 28.
10
Procedural safety and outcome of ultrathin strut stents (<60 μm) in the management of very long coronary artery stenosis (>30 mm) - A retrospective real world study.超薄支架（<60μm）治疗超长冠状动脉狭窄（>30mm）的手术安全性及预后——一项回顾性真实世界研究
Am J Cardiovasc Dis. 2020 Aug 15;10(3):182-188. eCollection 2020.
引用本文的文献
1
Stent Thrombosis and Restenosis with Contemporary Drug-Eluting Stents: Predictors and Current Evidence.当代药物洗脱支架的支架内血栓形成与再狭窄：预测因素及当前证据
J Clin Med. 2023 Feb 3;12(3):1238. doi: 10.3390/jcm12031238.
2
Safety and Clinical Performance of Biodegradable Polymer-Coated Ultra-Thin Everolimus-Eluting Stents in "Real-World" Patients: A Multicenter Registry (PERFORM-EVER).生物可降解聚合物涂层超薄依维莫司洗脱支架在“真实世界”患者中的安全性和临床性能：多中心注册研究（PERFORM-EVER）。
Anatol J Cardiol. 2022 Aug;26(8):619-628. doi: 10.5152/AnatolJCardiol.2022.844.
3
Recent Advances in Stent Technology: Do They Reduce Cardiovascular Events?支架技术的最新进展：它们是否降低心血管事件？
Curr Atheroscler Rep. 2022 Sep;24(9):731-744. doi: 10.1007/s11883-022-01049-z. Epub 2022 Jul 11.
4
Comparison of neointimal coverage between ultrathin biodegradable polymer-coated sirolimus-eluting stents and durable polymer-coated everolimus-eluting stents: 6 months optical coherence tomography follow-up from the TAXCO study.TAXCO 研究 6 个月光学相干断层成像随访：超薄可生物降解聚合物涂层西罗莫司洗脱支架与持久聚合物涂层依维莫司洗脱支架的新生内膜覆盖率比较。
Catheter Cardiovasc Interv. 2021 Feb 15;97(3):423-430. doi: 10.1002/ccd.28833. Epub 2020 Apr 3.
5
Triglyceride to high-density lipoprotein cholesterol ratio as a risk factor of repeat revascularization among patients with acute coronary syndrome after first-time percutaneous coronary intervention.甘油三酯与高密度脂蛋白胆固醇比值作为首次经皮冠状动脉介入治疗后急性冠状动脉综合征患者再次血运重建的危险因素。
J Thorac Dis. 2019 Dec;11(12):5087-5095. doi: 10.21037/jtd.2019.12.26.
本文引用的文献
1
Final five-year clinical outcomes in the EVOLVE trial: a randomised evaluation of a novel bioabsorbable polymer-coated, everolimus-eluting stent.EVOLVE 试验的最终 5 年临床结果：一种新型可生物吸收聚合物涂层、依维莫司洗脱支架的随机评估。
EuroIntervention. 2018 Apr 20;13(17):2047-2050. doi: 10.4244/EIJ-D-17-00529.
2
Ultrathin, bioresorbable polymer sirolimus-eluting stents versus thin, durable polymer everolimus-eluting stents in patients undergoing coronary revascularisation (BIOFLOW V): a randomised trial.冠状动脉血运重建患者中应用超薄可生物吸收聚合物西罗莫司洗脱支架与薄型持久聚合物依维莫司洗脱支架（BIOFLOW V）：一项随机试验
Lancet. 2017 Oct 21;390(10105):1843-1852. doi: 10.1016/S0140-6736(17)32249-3. Epub 2017 Aug 26.
3
Real-life clinical outcomes with everolimus eluting platinum chromium stent with an abluminal biodegradable polymer in patients from the Swedish Coronary Angiography and Angioplasty Registry (SCAAR).来自瑞典冠状动脉造影和血管成形术登记处（SCAAR）的患者使用载有依维莫司的铂铬合金支架及管腔外可生物降解聚合物的实际临床结果。
Catheter Cardiovasc Interv. 2017 Nov 15;90(6):881-887. doi: 10.1002/ccd.27030. Epub 2017 May 22.
4
Angiographic outcomes of Orsiro biodegradable polymer sirolimus-eluting stents and Resolute Integrity durable polymer zotarolimus-eluting stents: results of the ORIENT trial.奥西罗生物可降解聚合物西罗莫司洗脱支架与雷索卢特整合型耐用聚合物佐他莫司洗脱支架的血管造影结果：ORIENT试验结果
EuroIntervention. 2017 Jan 20;12(13):1623-1631. doi: 10.4244/EIJ-D-16-00179.
5
Randomized Comparison of a Biodegradable Polymer Ultrathin Strut Sirolimus-Eluting Stent With a Biodegradable Polymer Biolimus-Eluting Stent in Patients Treated With Percutaneous Coronary Intervention: The SORT OUT VII Trial.经皮冠状动脉介入治疗患者中可生物降解聚合物超薄支柱西罗莫司洗脱支架与可生物降解聚合物比伐卢定洗脱支架的随机对照比较：SORT OUT VII试验
Circ Cardiovasc Interv. 2016 Jul;9(7). doi: 10.1161/CIRCINTERVENTIONS.115.003610.
6
Real-world experience with a novel biodegradable polymer sirolimus-eluting stent: twelve-month results of the BIOFLOW-III registry.新型可生物降解聚合物西罗莫司洗脱支架的真实世界经验：BIOFLOW-III注册研究的12个月结果。
EuroIntervention. 2016 Feb;11(10):1106-10. doi: 10.4244/EIJY15M03_08.
7
Comparison of a novel biodegradable polymer sirolimus-eluting stent with a durable polymer everolimus-eluting stent: results of the randomized BIOFLOW-II trial.新型可生物降解聚合物西罗莫司洗脱支架与耐用聚合物依维莫司洗脱支架的比较：随机BIOFLOW-II试验结果
Circ Cardiovasc Interv. 2015 Feb;8(2):e001441. doi: 10.1161/CIRCINTERVENTIONS.114.001441.
8
Ultrathin strut biodegradable polymer sirolimus-eluting stent versus durable polymer everolimus-eluting stent for percutaneous coronary revascularisation (BIOSCIENCE): a randomised, single-blind, non-inferiority trial.超薄支架可生物降解聚合物西罗莫司洗脱支架与耐用聚合物依维莫司洗脱支架经皮冠状动脉血运重建（BIOSCIENCE）：一项随机、单盲、非劣效性试验。
Lancet. 2014 Dec 13;384(9960):2111-22. doi: 10.1016/S0140-6736(14)61038-2. Epub 2014 Sep 1.
9
10
A randomized, prospective, intercontinental evaluation of a bioresorbable polymer sirolimus-eluting coronary stent system: the CENTURY II (Clinical Evaluation of New Terumo Drug-Eluting Coronary Stent System in the Treatment of Patients with Coronary Artery Disease) trial.一种生物可吸收聚合物西罗莫司洗脱冠状动脉支架系统的随机、前瞻性、洲际评估：CENTURY II（新型泰尔茂药物洗脱冠状动脉支架系统治疗冠状动脉疾病患者的临床评估）试验。
Eur Heart J. 2014 Aug 7;35(30):2021-31. doi: 10.1093/eurheartj/ehu210. Epub 2014 May 19.
Zotero 插件